Samodzielny Publiczny Dziecięcy Szpital Kliniczny
Warsaw, 01-184, Poland
NCT Number: NCT01625273
The primary hypothesis is that Lactobacillus paracasei ssp. paracasei strain F19 in an infant formula containing FOS/GOS is safe and tolerable for use in infants from 0 to 6 months.
Looking for future studies?
Notify Me1 day–28 day
All sexes
Interventional
Not applicable
Warsaw, 01-184, Poland
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Provided in an infant formula, 10^8 CFU per day from 28 days to 6 months of infant age
Other names: F19
Time frame: From 28 days to 6 months
Arla Foods
Industry
Supplementation of Infant Formula With the Synbiotics (Lactobacillus Paracasei Ssp. Paracasei Strain F19 and Fructo- and Galactooligosaccharides).
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06318117
Infant Formula
Auxerre, France
View Trial DetailsNCT05295030
Breast Milk, Infant Formula
Guangzhou, Guangdong, China
View Trial DetailsNCT05224947
Infant Formula
Wageningen, Gelderland, Netherlands
View Trial DetailsNCT03456934
Body Weight, Growth
London, United Kingdom
View Trial Details